251 related articles for article (PubMed ID: 1974025)
1. Effects of ketone bodies on carbohydrate metabolism in non-insulin-dependent (type II) diabetes mellitus.
Henry RR; Brechtel G; Lim KH
Metabolism; 1990 Aug; 39(8):853-8. PubMed ID: 1974025
[TBL] [Abstract][Full Text] [Related]
2. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
Beylot M; Khalfallah Y; Riou JP; Cohen R; Normand S; Mornex R
J Clin Endocrinol Metab; 1986 Jul; 63(1):9-15. PubMed ID: 3519651
[TBL] [Abstract][Full Text] [Related]
3. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat.
Bieberdorf FA; Chernick SS; Scow RO
J Clin Invest; 1970 Sep; 49(9):1685-93. PubMed ID: 5452413
[TBL] [Abstract][Full Text] [Related]
5. Suppression of glucose production and stimulation of insulin secretion by physiological concentrations of ketone bodies in man.
Miles JM; Haymond MW; Gerich JE
J Clin Endocrinol Metab; 1981 Jan; 52(1):34-7. PubMed ID: 7005257
[TBL] [Abstract][Full Text] [Related]
6. Effects of free fatty acids and ketone bodies on in vivo non-insulin-mediated glucose utilization and production in humans.
Baron AD; Brechtel G; Edelman SV
Metabolism; 1989 Nov; 38(11):1056-61. PubMed ID: 2682134
[TBL] [Abstract][Full Text] [Related]
7. Serum ketone response to glucagon as a marker of insulin dependency in diabetics.
Watanabe T; Sugiyama H; Uchimura I; Maezawa H
Diabetes Res Clin Pract; 1991 Nov; 14(2):107-12. PubMed ID: 1756681
[TBL] [Abstract][Full Text] [Related]
8. Effect of ketone bodies on glucose production and utilization in the miniature pig.
Müller MJ; Paschen U; Seitz HJ
J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
[TBL] [Abstract][Full Text] [Related]
9. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
Weiss M; Keller U; Stauffacher W
Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
[TBL] [Abstract][Full Text] [Related]
10. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
[TBL] [Abstract][Full Text] [Related]
11. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
12. Role of glucagon in enhancing ketone body production in ketotic diabetic man.
Keller U; Schnell H; Sonnenberg GE; Gerber PP; Stauffacher W
Diabetes; 1983 May; 32(5):387-91. PubMed ID: 6132846
[TBL] [Abstract][Full Text] [Related]
13. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
[TBL] [Abstract][Full Text] [Related]
14. The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle.
Nosadini R; Alberti KG; Johnston DG; Del Prato S; Marescotti C; Duner E
Metabolism; 1981 Jun; 30(6):563-7. PubMed ID: 6112656
[TBL] [Abstract][Full Text] [Related]
15. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
16. Failure of glucagon to stimulate ketone body production during acute insulin deficiency or insulin replacement in man.
Sonnenberg GE; Stauffacher W; Keller U
Diabetologia; 1982 Aug; 23(2):94-100. PubMed ID: 6127275
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid-independent inhibition of hepatic ketone body production by insulin in humans.
Keller U; Gerber PP; Stauffacher W
Am J Physiol; 1988 Jun; 254(6 Pt 1):E694-9. PubMed ID: 3287950
[TBL] [Abstract][Full Text] [Related]
18. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
Avogaro A; Valerio A; Gnudi L; Maran A; Miola M; Duner E; Marescotti C; Iori E; Tiengo A; Nosadini R
Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
[TBL] [Abstract][Full Text] [Related]
19. The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients.
Greco AV; Mingrone G; Capristo E; Benedetti G; De Gaetano A; Gasbarrini G
Nutrition; 1998 Apr; 14(4):351-7. PubMed ID: 9591306
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.
Berrish TS; Hetherington CS; Alberti KG; Walker M
Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
